Patents by Inventor Friederike Wirtz-Brugger

Friederike Wirtz-Brugger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
    Publication number: 20080033005
    Abstract: Certain compounds, including 5,6-dihydro-3,9-dihydroxyindolo[2,1-a-isoquinolin12yl)[4-[2-(1-piperidinyl)ethoxy]phenyl]-methanone and arzoxifen, are useful for providing protection to oligodendrocytes and neurons of multiple sclerosis patients.
    Type: Application
    Filed: June 18, 2007
    Publication date: February 7, 2008
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: Jean MERRILL, Sandrines FUNES, Wayne PETKO, Friederike WIRTZ-BRUGGER, Karen CHANDROSS
  • USE OF CERTAIN PHENYL-NAPHTHYL COMPOUNDS THAT DO NOT HAVE SIGNIFICANT AFFINITY TO ER ALPHA OR ER BETA FOR PROTECTION OF NEURONS AND OLIGODENDROCYTES IN THE TREATMENT OF MULTIPLE SCLEROSIS
    Publication number: 20070225330
    Abstract: The invention provides a new use for certain SERM-like phenylnaphthyl compounds that do not exhibit affinity for alpha or beta type estrogen receptors (ER) in the treatment of multiple sclerosis.
    Type: Application
    Filed: June 6, 2007
    Publication date: September 27, 2007
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: Jean MERRILL, Sandrines FUNES, Wayne PETKO, Friederike WIRTZ-BRUGGER, Karen CHANDROSS
  • Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders
    Patent number: 7132428
    Abstract: Compounds of the formula I are suitable for producing pharmaceuticals for the prophylaxis and therapy of diseases whose course involves an increased activity of NIK.
    Type: Grant
    Filed: July 3, 2003
    Date of Patent: November 7, 2006
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Tahir Nadeem Majid, Corey Hopkins, Brian Leslie Pedgrift, Nicola Collar, Friederike Wirtz-Brugger, Jean Merrill
  • Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders
    Publication number: 20050009859
    Abstract: Compounds of the formula I are suitable for producing pharmaceuticals for the prophylaxis and therapy of diseases whose course involves an increased activity of NIK.
    Type: Application
    Filed: July 3, 2003
    Publication date: January 13, 2005
    Applicant: Aventis Pharmaceuticals Inc.
    Inventors: Tahir Majid, Corey Hopkins, Brian Pedgrift, Nicola Collar, Friederike Wirtz-Brugger, Jean Merrill